Search Results - "Hallahan, T. W."

Refine Results
  1. 1

    Impact of nuchal translucency credentialing by the FMF, the NTQR or both on screening distributions and performance by Evans, M. I., Krantz, D. A., Hallahan, T. W., Sherwin, J.

    Published in Ultrasound in obstetrics & gynecology (01-02-2012)
    “…Objective In the USA, both The Fetal Medicine Foundation (FMF) and the Nuchal Translucency Quality Review Program (NTQR) have operated education, review and…”
    Get full text
    Journal Article
  2. 2

    Genetic sonography after first‐trimester Down syndrome screening by Krantz, D. A., Hallahan, T. W., Macri, V. J., Macri, J. N.

    Published in Ultrasound in obstetrics & gynecology (01-06-2007)
    “…Objective Approximately 90% of Down syndrome cases are detected during first‐trimester screening. We aimed to determine the potential effectiveness of…”
    Get full text
    Journal Article
  3. 3

    Cell‐free fetal DNA screening in the USA: a cost analysis of screening strategies by Evans, M. I., Sonek, J. D., Hallahan, T. W., Krantz, D. A.

    Published in Ultrasound in obstetrics & gynecology (01-01-2015)
    “…ABSTRACT Objectives To determine whether implementation of primary cell‐free fetal DNA (cffDNA) screening would be cost‐effective in the USA and to evaluate…”
    Get full text
    Journal Article
  4. 4

    First‐trimester screening for fetal aneuploidy: biochemistry and nuchal translucency by Orlandi, F., Damiani, G., Hallaban, T. W., Krantz, D. A., Macri, J. N.

    Published in Ultrasound in obstetrics & gynecology (01-12-1997)
    “…Maternal dried whole‐blood specimens were collected prospectively from 2010 singleton pregnancies between 9 + 0 and 13 + 4 weeks that included 18 chromosomally…”
    Get full text
    Journal Article
  5. 5

    Genetic Sonography After First-trimester Down Syndrome Screening by Krantz, D A, Hallahan, T W, Macri, V J, Macri, J N

    Published in Obstetrical & gynecological survey (01-09-2007)
    “…Although second-trimester Down syndrome screening using maternal analytes was long accepted as the standard of care, first-trimester screening using both…”
    Get full text
    Journal Article
  6. 6

    Dual Site Model for the Organogenic Activity of Angiogenin by Hallahan, Terrence W., Shapiro, Robert, Vallee, Bert L.

    “…The residues that are indispensable for the ribonucleolytic activity of angiogenin are also known to be essential for its angiogenic activity. We now…”
    Get full text
    Journal Article
  7. 7

    Maternal serum levels of free β-hCG and PAPP-A in the first trimester of pregnancy are not associated with subsequent fetal growth retardation or preterm delivery by Morssink, L. P., Kornman, L. H., Hallahan, T. W., Kloosterman, M. D., Beekhuis, J. R., de Wolf, B. T. H. M., Mantingh, A.

    Published in Prenatal diagnosis (01-02-1998)
    “…The purpose of this case–control study was to examine the association of first‐trimester concentrations of free β‐human chorionic gonadotropin (free β‐hCG) and…”
    Get full text
    Journal Article
  8. 8
  9. 9
  10. 10

    Importance of asparagine-61 and asparagine-109 to the angiogenic activity of human angiogenin by Hallahan, Terrence W, Shapiro, Robert, Strydom, Daniel J, Vallee, Bert L

    Published in Biochemistry (Easton) (01-09-1992)
    “…Two distinct regions of angiogenin are critical for angiogenic activity: a catalytic site capable of cleaving RNA and a noncatalytic site, encompassing…”
    Get full text
    Journal Article
  11. 11

    First-Trimester down syndrome screening using dried blood biochemistry and nuchal translucency by Krantz, David A, Hallahan, Terrence W, Orlandi, Francesco, Buchanan, Philip, Larsen, John W, Macri, James N

    Published in Obstetrics and gynecology (New York. 1953) (01-08-2000)
    “…Objective: To assess the effectiveness of free β-hCG, pregnancy-associated plasma protein A, and nuchal translucency in a prospective first-trimester prenatal…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14
  15. 15

    Comparison of urinary free beta (hCG) and beta-core (hCG) in prenatal screening for chromosomal abnormalities by Hallahan, Terrence W., Krantz, David A., Tului, Lucia, Alberti, Ezio, Buchanan, Philip D., Orlandi, Francesco, Klein, Victor, Larsen Jr, John W., Macri, James N.

    Published in Prenatal diagnosis (01-09-1998)
    “…To evaluate the potential utility of free beta (hCG) and beta‐core (hCG) in a prenatal screening protocol for Down syndrome we analysed these markers in dried…”
    Get full text
    Journal Article
  16. 16

    Monoterpene biosynthesis: demonstration of a geranyl pyrophosphate:sabinene hydrate cyclase in soluble enzyme preparations from sweet marjoram (Majorana hortensis) by Hallahan, T W, Croteau, R

    Published in Archives of biochemistry and biophysics (01-08-1988)
    “…A soluble enzyme preparation from the leaves of sweet marjoram (Majorana hortensis Moench) catalyzes the divalent cation-dependent cyclization of [1-3H]geranyl…”
    Get more information
    Journal Article
  17. 17

    Monoterpene biosynthesis: mechanism and stereochemistry of the enzymatic cyclization of geranyl pyrophosphate to (+)-cis- and (+)-trans-sabinene hydrate by Hallahan, T W, Croteau, R

    Published in Archives of biochemistry and biophysics (15-02-1989)
    “…The conversion of geranyl pyrophosphate to (+)-cis- and (+)-trans-sabinene hydrate by a partially purified cyclase from sweet marjoram (Majorana hortensis) is…”
    Get more information
    Journal Article
  18. 18

    Hydrolysis of dolichyl esters by oviduct membranes and characterization of endogenous dolichyl esters by Malvar, T M, Hallahan, T W, Beach, D H, Lucas, J J

    Published in Archives of biochemistry and biophysics (01-05-1985)
    “…The chick oviduct system has been employed to study whether dolichol esters might serve as a storage form of dolichol to be converted to dolichyl phosphate…”
    Get more information
    Journal Article
  19. 19
  20. 20

    First-trimester screening for trisomy-21 using a simplified method to assess the presence or absence of the fetal nasal bone by Orlandi, Francesco, Rossi, Cinzia, Orlandi, Emanuela, Jakil, Maria Cristina, Hallahan, Terrence W., Macri, V. James, Krantz, David A.

    “…To determine the benefit of including nasal bone assessment in addition to standard first-trimester markers (nuchal translucency, free beta human chorionic…”
    Get full text
    Journal Article